Insulin glargine biosimilar multiple manufacturers

Indicated For

diabetes mellitus

About This Medication

# Civica Rx Insulin Glargine-yfgn Patient Guide: How to Get Insulin Glargine-yfgn at Low or No Cost Insulin glargine-yfgn is a **long-acting insulin** biosimilar manufactured by Biocon Biologics and distributed through Civica Rx, designed to help manage blood sugar levels in people with type 1 or type 2 diabetes. While Civica Rx does not currently offer a dedicated patient assistance program with detailed eligibility criteria, income thresholds, or a formal application process, patients can access this affordable insulin option through trial programs, pharmacy substitutions, low cash prices, and manufacturer savings for similar products[2][3]. ## About Insulin Glargine-yfgn **Insulin glargine-yfgn** is a biosimilar to insulin glargine (like Lantus), meaning it has no clinically meaningful differences in safety, purity, or potency. It provides a steady release of insulin over 24 hours to control basal (background) blood sugar levels, reducing the need for frequent injections. It's available in pens or vials and is often pharmacist-substitutable for brand-name versions, making it a cost-effective choice[3][2]. Civica Rx partners with Biocon Biologics to produce this insulin with the goal of improving access and lowering prices amid the insulin affordability crisis. Typical cash prices are around **$55 per box of 5 pens**, significantly less than many branded insulins[3]. It's prescribed for adults and children (depending on the condition) to help prevent high blood sugar complications like nerve damage, kidney issues, or heart disease. **Important:** Always consult your healthcare provider before starting or switching insulins, as dosing must be individualized based on your needs, diet, exercise, and other medications. ## Who Qualifies for Assistance? No specific patient assistance program (PAP) from Civica Rx or Biocon Biologics is detailed with income limits, but general pathways exist: - **Uninsured patients**: Eligible for trial vouchers (one-time free supply) if new to the product[2]. Low cash price at pharmacies[3]. - **Commercially insured**: May use pharmacy substitution; copay cards from similar manufacturers cap costs at $35/month[1][3]. - **Medicare patients**: Part D caps insulin at **$35/month per product** (no deductible); tubed pump users also capped at $35 via Part B[3][4]. - **Income-based aid**: No FPL thresholds listed for Civica, but explore general programs like manufacturer PAPs or state assistance[4]. Since program details like income thresholds (e.g., 400-500% FPL common in PAPs) are unavailable, focus on universal access routes[1][2][3]. ## Income Eligibility Breakdown Civica Rx does not publish income thresholds. Here's a comparison of typical insulin programs for context: | Household Size | Common PAP Threshold (e.g., 400-500% FPL) | Medicare Part D Insulin Cap | Cash/Trial Price for Insulin Glargine-yfgn | |----------------|--------------------------------------------|-----------------------------|--------------------------------------------| | Individual | ~$60,000-$75,000 | $35/month | $55/box of 5 pens[3] | | Couple | ~$80,000-$100,000 | $35/month | Trial: Free (new users)[2] | | Family of 3 | ~$100,000-$125,000 | $35/month | N/A | | Family of 4 | ~$120,000-$150,000 | $35/month | N/A | *Notes: FPL varies yearly; check HHS.gov for current. Civica emphasizes low-cost supply over income-based aid[3].* ## Insurance Requirements - **Commercial insurance**: Allowed; trial voucher requires coverage or uninsured status[2]. Copay programs from similar insulins (e.g., Sanofi, Lilly) reduce costs to $35 but may not count toward deductibles[1][3]. - **Medicare**: Fully covered under Part D ($35 cap) or Part B for pumps; no copay cards[3][4]. - **Medicaid/VA/TRICARE**: Coverage typically available; trial voucher eligible[2]. - **Uninsured**: Best cash price or trial[2][3]. No restrictions noted for government programs, but confirm with your plan. ## Step-by-Step Application Process 1. **Get a prescription**: Ask your doctor for insulin glargine-yfgn (5 pens or 2 vials). Request pharmacist substitution if needed[2][3]. 2. **Trial voucher (new users)**: Healthcare provider completes McKesson form at mprsetrial.mckesson.com/8132/ for free 5 pens/2 vials. Eligible if uninsured or insured (including Medicare/Medicaid)[2]. 3. **Pharmacy fill**: Present Rx; pay ~$55 cash or use insurance ($35 cap for Medicare). For similar insulins, get savings card (e.g., Sanofi at 866-255-8661)[1]. 4. **Explore alternatives**: If unavailable, use biosimilars like Semglee or Rezvoglar ($35 with coupons)[3]. 5. **Contact support**: Biocon/Civica details limited; call pharmacy or Lilly/Sanofi for guidance[1][3]. No formal online application or phone listed for Civica PAP. ## Timeline and Delivery - **Trial voucher**: Provider submits; patient receives at pharmacy with Rx. Processing: Days to weeks[2]. - **Pharmacy**: Immediate upon fill; mail-order possible via insurance. - **Refills**: Not covered by trial; standard Rx refills monthly[1]. - **Delivery**: Pharmacy pickup or mail (e.g., $35/month programs)[1][3]. Expect 1-3 days for standard fills. ## Alternatives if Denied or Ineligible - **Biosimilars**: **Semglee (Biocon)** or **Rezvoglar (Lilly)** – $35/month with coupons[3]. - **Other programs**: Sanofi Insulins Valyou ($35 uninsured), LillyDirect, NovoCare PAP (income-based free insulin)[1][4][5]. - **Medicare cap**: Automatic $35[3]. - **General aid**: Simplefill (877-386-0206), Breakthrough T1D resources[3][8]. ## Disclaimer This guide is for informational purposes only and based on available public data as of 2026. Program details can change; Civica Rx lacks a full PAP, so verify with healthcare provider, pharmacist, or manufacturer. Not medical advice – consult professionals for personalized care. Void where prohibited. Out-of-pocket costs may not apply to deductibles[1][2][3]. (Word count: 1028)

Program information last verified: March 30, 2026